HUP0001747A3 - 1h-benzo[+]isoindole derivatives as farnesyl transferase inhibitor, process for producing them and use of them for process pharmaceutical compositions - Google Patents

1h-benzo[+]isoindole derivatives as farnesyl transferase inhibitor, process for producing them and use of them for process pharmaceutical compositions

Info

Publication number
HUP0001747A3
HUP0001747A3 HU0001747A HUP0001747A HUP0001747A3 HU P0001747 A3 HUP0001747 A3 HU P0001747A3 HU 0001747 A HU0001747 A HU 0001747A HU P0001747 A HUP0001747 A HU P0001747A HU P0001747 A3 HUP0001747 A3 HU P0001747A3
Authority
HU
Hungary
Prior art keywords
benzo
producing
pharmaceutical compositions
transferase inhibitor
farnesyl transferase
Prior art date
Application number
HU0001747A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of HUP0001747A2 publication Critical patent/HUP0001747A2/hu
Publication of HUP0001747A3 publication Critical patent/HUP0001747A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/724,7-Endo-alkylene-iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0001747A 1996-12-30 1997-12-23 1h-benzo[+]isoindole derivatives as farnesyl transferase inhibitor, process for producing them and use of them for process pharmaceutical compositions HUP0001747A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9616206A FR2757855B1 (fr) 1996-12-30 1996-12-30 Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/002407 WO1998029390A1 (fr) 1996-12-30 1997-12-23 Inhibiteurs de farnesyle transferase

Publications (2)

Publication Number Publication Date
HUP0001747A2 HUP0001747A2 (hu) 2000-09-28
HUP0001747A3 true HUP0001747A3 (en) 2000-10-30

Family

ID=9499293

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001747A HUP0001747A3 (en) 1996-12-30 1997-12-23 1h-benzo[+]isoindole derivatives as farnesyl transferase inhibitor, process for producing them and use of them for process pharmaceutical compositions

Country Status (32)

Country Link
EP (1) EP0948483B1 (en])
JP (1) JP2001509147A (en])
KR (1) KR20000062391A (en])
AR (1) AR008950A1 (en])
AT (1) ATE214367T1 (en])
AU (1) AU741921B2 (en])
BR (1) BR9714498A (en])
CA (1) CA2275943A1 (en])
CO (1) CO4920252A1 (en])
CZ (1) CZ233599A3 (en])
DE (1) DE69711081T2 (en])
DK (1) DK0948483T3 (en])
DZ (1) DZ2389A1 (en])
EA (1) EA002114B1 (en])
ES (1) ES2172033T3 (en])
FR (1) FR2757855B1 (en])
HU (1) HUP0001747A3 (en])
ID (1) ID22922A (en])
IL (1) IL130453A0 (en])
MA (1) MA26460A1 (en])
NO (1) NO993225L (en])
NZ (1) NZ336042A (en])
PE (1) PE28199A1 (en])
PL (1) PL334345A1 (en])
PT (1) PT948483E (en])
SK (1) SK88399A3 (en])
TN (1) TNSN97214A1 (en])
TR (1) TR199901502T2 (en])
UY (1) UY24832A1 (en])
WO (1) WO1998029390A1 (en])
YU (1) YU30299A (en])
ZA (1) ZA9711734B (en])

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (fr) * 1998-12-21 2003-01-17 Aventis Pharma Sa Compositions contenant des inhibiteurs de farnesyle transferase
FR2796641B1 (fr) * 1999-07-22 2001-09-21 Aventis Pharma Sa Nouveau procede de preparation de composes benzoperhydroisoindole
FR2796640A1 (fr) * 1999-07-22 2001-01-26 Aventis Pharma Sa Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la preparation de medicaments
FR2845994B1 (fr) * 2002-10-18 2006-05-19 Servier Lab Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20060106060A1 (en) * 2004-03-18 2006-05-18 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies (Lansbury)
TW202508595A (zh) 2023-05-04 2025-03-01 美商銳新醫藥公司 用於ras相關疾病或病症之組合療法
WO2025080946A2 (en) 2023-10-12 2025-04-17 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730605A1 (en) * 1993-11-05 1996-09-11 Warner-Lambert Company Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
FR2736641B1 (fr) * 1995-07-10 1997-08-22 Rhone Poulenc Rorer Sa Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HUP0001747A2 (hu) 2000-09-28
EP0948483A1 (fr) 1999-10-13
MA26460A1 (fr) 2004-12-20
ATE214367T1 (de) 2002-03-15
AR008950A1 (es) 2000-02-23
NO993225L (no) 1999-08-24
AU741921B2 (en) 2001-12-13
BR9714498A (pt) 2000-03-21
DE69711081D1 (de) 2002-04-18
CO4920252A1 (es) 2000-05-29
DZ2389A1 (fr) 2002-12-28
FR2757855B1 (fr) 1999-01-29
SK88399A3 (en) 2000-05-16
YU30299A (sh) 2002-03-18
EP0948483B1 (fr) 2002-03-13
CZ233599A3 (cs) 1999-09-15
JP2001509147A (ja) 2001-07-10
TR199901502T2 (xx) 1999-09-21
PL334345A1 (en) 2000-02-28
ID22922A (en]) 1999-12-16
FR2757855A1 (fr) 1998-07-03
UY24832A1 (es) 2001-08-27
IL130453A0 (en) 2000-06-01
NO993225D0 (no) 1999-06-29
EA199900608A1 (ru) 2000-02-28
TNSN97214A1 (fr) 2005-03-15
WO1998029390A1 (fr) 1998-07-09
NZ336042A (en) 2000-12-22
AU5669498A (en) 1998-07-31
ES2172033T3 (es) 2002-09-16
ZA9711734B (en) 1998-06-25
PT948483E (pt) 2002-08-30
DE69711081T2 (de) 2002-08-01
CA2275943A1 (fr) 1998-07-09
KR20000062391A (ko) 2000-10-25
PE28199A1 (es) 1999-06-05
EA002114B1 (ru) 2001-12-24
DK0948483T3 (da) 2002-07-01

Similar Documents

Publication Publication Date Title
HUP9802857A3 (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors, process for producing them and pharmaceutical compositions containing them
CZ5498A3 (cs) Nové inhibitory farnesyl-transferázy, způsob jejich přípravy a farmaceutické kompozice tyto inhibitory obsahující
AU6523396A (en) Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors
AU4543696A (en) Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
AU4722796A (en) Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
AU4722896A (en) Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
HUP9802315A3 (en) Thrombin inhibitors, process for producing them and use of them for producing pharmaceutical compositions
HUP0001498A3 (en) Farnesyl transferase inhibiting 1,8-annelated imidazolyl-quinolinone derivatives, their intermediates, pharmaceutical compositions thereof and process for their preparation
AU1912197A (en) New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
HU9402232D0 (en) 1-benzene-sulfonyl-1,3-dihydro-indol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
HUP9900728A3 (en) Peptide derivatives as thrombin inhibitors, process for producing them and pharmaceutical compositions containing them
HUP0000323A3 (en) N-substituted 2-cyanopyrrolidine derivatives, process for producing them and pharmaceutical compositions containing them
IL117580A0 (en) Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
HUP0001285A3 (en) Pyrrolidine derivatives as protease inhibitors, process for producing them and pharmaceutical compositions containing them
HUP9904680A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them and process for their preparation
HUP9701264A3 (en) Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0001607A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
HUP0000610A3 (en) Piperidine derivatives, with analgesic effect, process for producing them and pharmaceutical compositions containing them
HUT77310A (hu) Alfa- és béta-polimorf formájú indolszármazék sók, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
HUP0000613A3 (en) Piperidine derivatives with analgesic effect process for producing them and pharmaceutical compositions containing them
HUP9801599A3 (en) Use of imidazolin derivatives having alfa1l agonist effect for producing pharmaceutical compositions for treatment of incontinence, novel imidazolin derivatives and process for producing them
HUP9701265A3 (en) Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them